Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Featured trial
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

  • 88 views
  • 08 Nov, 2020
  • 1 location
Digoxin Short Term Treatment Assessment Randomized Trial in AHF (DIG-STA-AHF)

> Whether digoxin is efficient and safe in short term treatment of acute heart failure is a question that should be studied.

  • 5 views
  • 08 Jul, 2022
  • 2 locations
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction

The purpose of this study is to evaluate the safety, pharmacokinetics, and effect on cardiac function of intravenous APD418 in adult participants with heart failure with reduced ejection fraction (HFrEF).

  • 0 views
  • 23 Jul, 2022
  • 17 locations
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia (InSaKa)

Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbidities. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can be fatal …

  • 14 views
  • 26 Mar, 2022
  • 4 locations
Acute Heart Failure - COngestion Discharge Evaluation (AHF-CODE)

Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient

natriuretic peptide
congestion
pulmonary congestion
  • 0 views
  • 23 Mar, 2022
  • 1 location
Acute Heart Failure - COngestion Repeated Evaluation (AHF-CORE) (AHF-CORE)

ultrasound) at the beginning and at the end of hospitalization for acute heart failure that are more strongly associated with the risk of all cause death or rehospitalization for acute heart failure within 3

congestion
  • 7 views
  • 22 Jul, 2022
  • 2 locations
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

> The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk

  • 6 views
  • 30 Jan, 2021
  • 1 location
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are

  • 12 views
  • 02 Feb, 2021
  • 1 location
Effect of Dapagliflozin in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF)

Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i), increases natriuresis alone and synergistically when combined with loop diuretics in patients with AHF without increasing renin angiotensin- aldosterone activity. Thus, adding SGLT2i to the standard loop diuretic therapy might confer additional decongestive and natriuretic benefits while avoiding the adverse electrolyte abnormalities and neurohormonal …

  • 0 views
  • 19 Jun, 2022
  • 1 location
Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Acute Heart Failure (KETO-AHF1)

Background Acute heart failure is a potentially life-threatening condition, reaching mortality rates of up to 50% in advanced cases. The investigators have shown

maltodextrin
diuretics
3-hydroxybutyrate
loop diuretic
  • 0 views
  • 24 Jul, 2022
  • 1 location